107 related articles for article (PubMed ID: 20715187)
1. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
[TBL] [Abstract][Full Text] [Related]
2. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
3. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow.
Baek K; Cho JY; Hwang HR; Kwon A; Lee HL; Park HJ; Qadir AS; Ryoo HM; Woo KM; Baek JH
J Cell Physiol; 2012 Nov; 227(11):3603-12. PubMed ID: 22307523
[TBL] [Abstract][Full Text] [Related]
4. Zinc-finger transcription factor odd-skipped related 2 is one of the regulators in osteoblast proliferation and bone formation.
Kawai S; Yamauchi M; Wakisaka S; Ooshima T; Amano A
J Bone Miner Res; 2007 Sep; 22(9):1362-72. PubMed ID: 17547533
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
6. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.
Wang X; Kua HY; Hu Y; Guo K; Zeng Q; Wu Q; Ng HH; Karsenty G; de Crombrugghe B; Yeh J; Li B
J Cell Biol; 2006 Jan; 172(1):115-25. PubMed ID: 16380437
[TBL] [Abstract][Full Text] [Related]
7. Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice.
Nissen-Meyer LS; Jemtland R; Gautvik VT; Pedersen ME; Paro R; Fortunati D; Pierroz DD; Stadelmann VA; Reppe S; Reinholt FP; Del Fattore A; Rucci N; Teti A; Ferrari S; Gautvik KM
J Cell Sci; 2007 Aug; 120(Pt 16):2785-95. PubMed ID: 17652162
[TBL] [Abstract][Full Text] [Related]
8. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice.
Yu VW; Ambartsoumian G; Verlinden L; Moir JM; Prud'homme J; Gauthier C; Roughley PJ; St-Arnaud R
J Cell Biol; 2005 May; 169(4):591-601. PubMed ID: 15911876
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
10. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis.
Rasheed N; Wang X; Niu QT; Yeh J; Li B
Hum Mol Genet; 2006 Jun; 15(12):1938-48. PubMed ID: 16644862
[TBL] [Abstract][Full Text] [Related]
11. Climbing exercise increases bone mass and trabecular bone turnover through transient regulation of marrow osteogenic and osteoclastogenic potentials in mice.
Mori T; Okimoto N; Sakai A; Okazaki Y; Nakura N; Notomi T; Nakamura T
J Bone Miner Res; 2003 Nov; 18(11):2002-9. PubMed ID: 14606513
[TBL] [Abstract][Full Text] [Related]
12. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.
Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T
J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918
[TBL] [Abstract][Full Text] [Related]
13. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
Wiren KM; Toombs AR; Semirale AA; Zhang X
Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.
Oshima K; Nampei A; Matsuda M; Iwaki M; Fukuhara A; Hashimoto J; Yoshikawa H; Shimomura I
Biochem Biophys Res Commun; 2005 Jun; 331(2):520-6. PubMed ID: 15850790
[TBL] [Abstract][Full Text] [Related]
16. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
17. Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
Günther T; Poli C; Müller JM; Catala-Lehnen P; Schinke T; Yin N; Vomstein S; Amling M; Schüle R
EMBO J; 2005 Sep; 24(17):3049-56. PubMed ID: 16079911
[TBL] [Abstract][Full Text] [Related]
18. The 3.6 kb DNA fragment from the rat Col1a1 gene promoter drives the expression of genes in both osteoblast and osteoclast lineage cells.
Boban I; Jacquin C; Prior K; Barisic-Dujmovic T; Maye P; Clark SH; Aguila HL
Bone; 2006 Dec; 39(6):1302-12. PubMed ID: 16938497
[TBL] [Abstract][Full Text] [Related]
19. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice.
Sobue T; Naganawa T; Xiao L; Okada Y; Tanaka Y; Ito M; Okimoto N; Nakamura T; Coffin JD; Hurley MM
J Cell Biochem; 2005 May; 95(1):83-94. PubMed ID: 15723277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]